Amydis, Inc.
Diagnostic compounds for molecular biomarker detection via ocular imaging
- Sector
- Medtech
- Headquarters
- LOS ANGELES, CA
- Latest Form D
- $3M, Dec 2023
- Total capital
- $14.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $14.7M
- 3 Form D · last Dec 2023
- 34 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 26 pending · first 2019
- Rank in peer group#2 of 29
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$3M
- Private capital raisedForm D · SEC · 2nd filing$6M
- Private capital raisedForm D · SEC · 1st filing$5.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 29 peers
Line = medianMedtech · Molecule
- Granted patents#2 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Stella SarrafResearcherExecutive Officer, DirectorLinked by 1 patent
- Christine AylwardDirectorNamed in SEC Form D filings
- Jack L. Thrift, CPAExecutive OfficerNamed in SEC Form D filings
- James KhodabakhshDirectorNamed in SEC Form D filings
- Jerre L. SteadDirectorNamed in SEC Form D filings
- Mervyn TurnerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 32- GrantedAmyloid Targeting Agents And Methods Of Using The SameUSPTOUS 12,741,949
- GrantedPhosphate Compounds For Detecting Neurological DisordersUSPTOUS 12,708,676
- PendingCompositions And Methods For Detection Of Traumatic Brain InjuryUSPTOApplication 19374985
Show all 32 patent records
- Amyloid Targeting Agents And Methods Of Using The SameSep 22, 2026 · US 12,741,949Granted
- Phosphate Compounds For Detecting Neurological DisordersAug 18, 2026 · US 12,708,676Granted
- Compositions And Methods For Detection Of Traumatic Brain InjuryJul 23, 2026 · Application 19374985Pending
- Compositions And Methods For Detection Of Traumatic Brain InjuryNov 25, 2025 · US 12,478,693Granted
- Phosphate Compounds For Detecting Neurological DisordersJul 3, 2025 · Application 18791326Pending
- N-heterocyclyl Substituted 2-CYANO-3-(NAPHTHALEN-2-YL)ACRYLAMIDE Derivatives As Fluorophors For Detection Of Amyloid And Amyloid-like Proteins For Diagnosis Of Neurodegenerative DisordersOct 3, 2024 · Application 18579251Pending
- Amyloid Targeting Agents And Methods Of Using The SameJun 27, 2024 · Application 18214841Pending
- Methods Of Detecting Systemic Amyloidosis Via Binding To Misfolded Or Aggregated ProteinMay 23, 2024 · Application 18550099Pending
- Phosphate Compounds For Detecting Neurological DisordersFeb 1, 2024 · Application 18193570Pending
- Amyloid Targeting Agents And Methods Of Using The SameAug 8, 2023 · US 11,718,596Granted
- Methods Of Detecting Neurological Disorders Via Binding To Phosphorylated Tau ProteinNov 24, 2022 · Application 17760854Pending
- Phosphate Compounds For Detecting Neurological DisordersJan 6, 2022 · Application 17290727Pending
- Amyloid Targeting Agents And Methods Of Using The SameMar 2, 2021 · US 10,934,264Granted
- Amyloid Targeting Agents And Methods Of Using The SameAug 6, 2019 · US 10,370,345Granted
- In Vitro Compositions Comprising Human Sample And Amyloid Targeting AgentAug 31, 2017 · Application 15508659Pending
- Amyloid Targeting AgentsApplication 63222380Pending
- Methods Of Detecting Systemic Amyloidosis Via Binding To Misfolded Or Aggregated ProteinApplication 63160602Pending
- Methods Of Detecting Systemic Amyloidosis Via Binding To Misfolded Or Aggregated ProteinApplication PCTUS2022020013Pending
- Amyloid Targeting AgentsApplication PCTUS2022037387Pending
- Methods Of Detecting Neurological Disorders Via Binding To Phosphorylated Tau ProteinApplication PCTUS2020051325Pending
- Phosphate Compounds For Detecting Neurological DisordersApplication PCTUS2019059538Pending
- Methods Of Detecting Neurological Disorders Via Binding To Phosphorylated Tau ProteinApplication 62902265Pending
- Amyloid Targeting AgentsApplication 63480453Pending
- Compositions And Methods For Detection Of Traumatic Brain InjuryApplication PCTUS2019034977Pending
- Phosphate Compounds For Detecting Neurological DisordersApplication 62855442Pending
- Amino Acid Derivatives For Detecting Neurological DisordersApplication 63602881Pending
- Amyloid Targeting AgentsApplication PCTUS2024011789Pending
- Phosphate Compounds For Detecting Neurological DisordersApplication 62755331Pending
- Compositions And Methods For Detection Of Traumatic Brain InjuryApplication 62733025Pending
- Compositions And Methods For Detection Of Traumatic Brain InjuryApplication 62678900Pending
- Amino Acid Derivatives For Detecting Neurological DisordersApplication PCTUS2024057469Pending
- Amyloid Targeting AgentsApplication 19146892Pending
Related companies, and why
- Xos, Inc.Similar federal contract value in Medtech · null in contracts
- Heru, Inc.Similar federal contract value in Medtech · null in contracts
- Summit Naturals Inc.Similar federal contract value in Medtech · null in contracts
- Perimetrics, Inc.Similar federal contract value in Medtech · null in contracts
- Waypoint Orthopedics, Inc.Similar federal contract value in Medtech · null in contracts
- RevOrtho LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .